Caxton Associates LP
- SEC CIK
- 0000872573
- Latest filing
- Feb 14, 2025
AMRX holding history
Amneal Pharmaceuticals, Inc. in every 13F filed by Caxton Associates LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMRX overviewAll 13F holders of AMRXFull Q4 2024 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −29,150−100.0% | Sold out | Holders |
| Q3 2024 | 29,150 | $242.5K | <0.1% | +29,150 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −91,481−100.0% | Sold out | Holders |
| Q1 2024 | 91,481 | $554.4K | <0.1% | +8,088+9.7% | Added | Holders |
| Q4 2023 | 83,393 | $506.2K | <0.1% | −36,887−30.7% | Reduced | Holders |
| Q3 2023 | 120,280 | $507.6K | 0.1% | +120,280 | New | Holders |